Note some links may be broken where content has subsequently been removed, and pages may have had further updates since those listed below.
31 December 2020 |
Update to DPD deficiency - see report for variants tested for. |
revision 2020.077 |
Amendment to heparin assay (Anti-Xa) - BSUH no longer using tinzaparin. |
revision 2020.076 | |
28 December 2020 |
Change to alkaline phosphatase isoenzymes range (adult female total ALP only). |
revision 2020.075 |
23 December 2020 |
On the 23rd December 2020 the biochemistry laboratory will be changing the method used for serum LDH analysis. This is due to the production of the current assay being discontinued by our supplier. You can expect results to be approximately 50% lower compared to the previous assay. There will be a comment on all reports highlighting that the test has been run using the new assay and there will be new reference ranges in use. Please exercise caution when comparing results from the new assay to previous results. |
revision 2020.074 |
Advance notice of equipment upgrade in biochemistry, Jan 2021.A new inductively coupled plasma mass spectrometer is being installed for our trace metal analysis. There will be a disruption to the service whilst this new piece of equipment is installed so turnaround times for serum copper, zinc and lead may be increased throughout January. Please contact the laboratory if any analysis is urgent. |
revision 2020.073 | |
16 December 2020 |
Amendment to time limit for sample processing for D-dimers. |
revision 2020.072 |
15 December 2020 |
New revision of Biochemistry telephoning ranges, downloadable under Reporting Results here. |
revision 2020.071 |
9 December 2020
|
Upndate to JC virus testing page. |
revision 2020.070 |
Information on VitaPCR test added to COVID-19 molecular testing page.
|
revision 2020.069 | |
Due to equipment failure there are currently delays to the turnaround times for serum and urine osmolality results as they are being referred to an external laboratory. Please consider the necessity of your requests and only request if clinically urgent. Where possible, please also try to send samples during routine hours. Consider also sending a fluoride oxalate sample for glucose measurement to allow for calculation of serum osmolarity where appropriate. |
||
Addition of calculation equations to serum osmolality page. |
revision 2020.068 | |
7 December 2020 |
From 14/12/20 the NSE service provided for ITU will be extended to cover weekends. Please contact the laboratory in advance if sample will be sent at the weekend. |
revision 2020.067 |
Update to Hove Polyclinic phlebotomy information, see Phlebotomy services page. | revision 2020.066 | |
16 November 2020 |
ESR and glandular fever screen - restricted test availability in suspected or confirmed COVID patients. | revision 2020.065 |
Lupus anticoagulant reference range updated. | revision 2020.064 | |
Additional information regarding heparin assay (Anti-Xa) reference ranges. | revision 2020.063 | |
Reference range added for beta carotene. | revision 2020.062 | |
11 November 2020 | Immunology mailbox and contact number for urgent results added here. | revision 2020.061 |
Correction to Abnormal LFT Screen profile. | revision 2020.060 | |
10 November 2020 | Addition of information regarding role of microbiologists in clinical advice, see Laboratory information (Microbiology). | revision 2020.059 |
4 November 2020 | We are moving over to a new generation of CRP reagent on Monday the 9th of November. There is a slight negative bias on the new method on values 100 mg/L and above. Results may be up to 10% lower than with previous method. | revision 2020.058 |
3 November 2020 | Change of sample type for P1NP. Due to a change in provider at the referral laboratory EDTA plasma is no longer accepted. A serum sample (gold top tube) is required for this test. | revision 2020.057 |
27th October 2020 | AMH reference to cut off for NHS funding of local fertility treatment has been removed. | revision 2020.056 |
Change of referral site for valproate. | revision 2020.055 | |
7th October 2020 |
National issues with Roche pathology supply chain - urgent requirement to reduce Blood Sciences Pathology requestsPathology services at BSUH use the pharmaceutical company Roche as the main supplier of pathology equipment and consumables. The supplies from Roche are used for the analysis of a large number of routine pathology blood sciences tests. On Tuesday Roche reported a national disruption to the supply chain, and issues with any orders that are due to be filled. At BSUH this has led to a temporary shortage in some of the chemicals we use to process test results. Roche are working urgently to resolve this. Within the trust we are doing everything we can to reduce the impact on our patients, including working locally with other NHS organisations to share stock. Action for service users In the first instance, we ask that departments where possible, immediately reduce their requests for blood tests by delaying tests for routine monitoring and considering clinical need. This will help pathology labs to manage the initial phase of this issue and means a wider pathology service can be available until the issues are resolved. However, if the issues persist we will implement a contingency plan to prioritise inpatients with acute needs. More information will be shared with you if this becomes necessary. |
|
12th October 2020 |
Minor change to CA15-3 reference range. |
revision 2020.054 |
Update to interferences for TPO antibody. |
revision 2020.053 | |
5th October 2020
|
Information on DPD deficiency testing added. |
revision 2020.052 |
New revision of patient instruction leaflet for post vasectomy specimens. |
revision 2020.051 | |
Microbiology & Infection content updated. |
revision 2020.050 | |
15 September 2020 |
Change to reference ranges for urine cortisol due to a change in provider at the referral laboratory. |
revision 2020.049 |
Turnaround time for faecal occult blood (FIT test) reduced to 2 days. |
revision 2020.048 | |
11 September 2020 |
Change to reference ranges for P1NP due to a change in provider at the referral laboratory. |
revision 2020.047 |
2 September 2020
|
Advance warning of change to LDH method. The current LDH assay is being phased out by the manufacturer by the end of December 2020. The new LDH assay is expected to produce results approximately 50% lower than the current method. |
revision 2020.046 |
Removal of references to cervical screening service - no longer provided by Frontier Pathology. |
revision 2020.045 | |
New revision of Pathology Specimen and Request Form Labelling Requirements. |
revision 2020.044 | |
18 August 2020 |
The reference ranges for P1NP will be changing from September 2020 due to a change in provider at the referral laboratory. |
revision 2020.043 |
17 August 2020 |
Content added to coronavirus (COVID-19) molecular testing page. |
revision 2020.042 |
10 August 2020 |
Addition of test indication information to the following haematology tests: bone marrow aspiration, ESR, FBC, G6PD screen, glandular fever screen, Heinz bodies, malarial parasites, plasma viscosity, pyruvate kinase (red cell) and reticulocytes. |
revision 2020.041 |
27 July 2020 |
Change to acetylcholine receptor antibody assay and reference range. | revision 2020.040 |
22 July 2020 |
Download for the request/ consent form for NHS & Social Care staff has been added to the anti-SARS-CoV-2 (COVID-19 antibody testing) page. (rescinded 27 July 2020 - COVID-19 antibody requesting for different staff and patient groups is being coordinated separately, currently at https://www.frontierpathology.nhs.uk/pug/Covid-19-Antibody-Patient-Testing however this is subject to change). |
revision 2020.039 |
20 July 2020 |
Normal OPD Phlebotomy hours resumed at PRH - click here. |
revision 2020.038 |
revision 2020.037 | ||
7 July 2020 |
New revision of Haematology document "Summary of actions to be taken on abnormal result" - downloadable here. |
revision 2020.036 |
New revision of Pathology Stores Request Form, including updated email address. |
revision 2020.035 | |
30 June 2020 |
Updates to turnaround times for several tests referred to Berkshire & Surrey Pathology Services, plus: Elastase (faeces) - addition of information regarding stopping pancreatic supplements prior to test. Methotrexate - change of sample type, plus clarification that test is only needed in monitoring drug clearance in high dose IV therapy. |
revision 2020.034 |
26 June 2020 |
Addition to faecal occult blood (FIT) regarding sample labelling. | revision 2020.033 |
Updated ethanol ranges. | revision 2020.032 | |
23 June 2020 | Amended OPD Phlebotomy hours at PRH - click here. | revision 2020.031 |
16 June 2020 | Update to gestational infections (ToRC) - diagnostic virology | revision 2020.030 |
Please send a separate sample to Blood Sciences If flow cytometry is required as part of CSF cytology. | revision 2020.029 | |
15 June 2020 |
Clarification of type of clotted blood requested for toxicology investigations (acute overdose and screening for drug use). |
revision 2020.028 |
1 June 2020
|
Anti-SARS-CoV-2 (COVID-19 antibodies) added. |
revision 2020.027 |
New page for LGI1 and CASPR2 antibodies added. |
revision 2020.026 | |
New referral site for NMDA receptor antibodies, LGI1 and CASPR2 antibodies and potassium channel antibody. |
revision 2020.025 | |
31 May 2020 |
Update to coronavirus (COVID-19) page. |
revision 2020.024 |
21 April 2020 |
Mobile replaces office extensions for Sarah Bastow, Head of Blood Sciences (see contacts). |
revision 2020.023 |
New target ranges for anticoagulation - see heparin assay (Anti-Xa). |
revision 2020.022 | |
APTT and prothrombin time added to Coagulation screen. |
revision 2020.021 | |
20 April 2020 |
Reference range for APTT ratio (see coagulation screen) amended to 2 decimal places to reflect reporting. |
revision 2020.020 |
8 April 2020 | Update to Heparin assay (Anti-Xa) | revision 2020.019 |
1 April 2020 | Accreditation re-instated for Microbiology & Infection | revision 2020.018 |
31 March 2020 |
Procalcitonin update - available in-house shortly. Click here to download guidelines on the use of procalcitonin in COVID-19. |
revision 2020.017 |
23 March 2020 |
Laboratory information relating to changes due to the Coronavirus (COVID-19) outbreak will be published on a separate page: |
revision 2020.016 |
17 March 2020 |
Coronavirus (COVID-19) For BSUH clinical procedures please go to the BSUH intranet page. The instructions for taking swabs and bloods to the lab in and out of hours, and for taking swabs for testing, can be downloaded here. |
revision 2020.015 |
9 March 2020 |
New reference ranges for platelet function studies. |
revision 2020.014 |
Updated TAT information for scrapings/ clippings for mycological investigation. |
revision 2020.013 |
|
2 March 2020 |
New reflex testing from 20th January 2020 for anti-drug antibody in infliximab and adalimumab testing. |
revision 2020.012 |
19 February 2020 |
New revision of 24h urine collection instructions, and new dietary restrictions leaflet for 5-HIAA and urine metadrenalines. Click here. |
revision 2020.011 |
18 February 2020 |
Update to Cellular Pathology and Cytopathology pages. |
revision 2020.010 |
Change of sample type for flecainide. |
revision 2020.009 |
|
3 February 2020 |
Addition of sample volume requirement to BCR-ABL. |
revision 2020.008 |
14 January 2020 |
New revisions of protocols for glucagon stimulation test for glycogen storage diseases, growth hormone response to oral glucose tolerance test, ischaemic forearm lactate & ammonia test, lactose tolerance test, pentagastrin test, short synacthen test, and water deprivation tests 1 to 3. No changes to procedures.See dynamic function tests. |
revision 2020.007 |
13 January 2020 |
Update to urine microbiology MSU sample information to reflect changes to collection kit. |
revision 2020.006 |
Addition of container requirements for calculi. |
revision 2020.005 | |
8 January 2020
|
The cut-offs for fasting plasma glucose and haemoglobin A1c have been amended in line with the NHS Diabetes Prevention Programme. |
revision 2020.004 |
Change to TAT and sample containers for scrapings/ clippings for mycological investigation. |
revision 2020.003 | |
Additions to factors affecting test performance/ results for serum sodium and potassium. |
revision 2020.002 | |
7 January 2020 |
New revisions of protocols for insulin stress test, overnight dexamethasone suppression test, glucagon stimulation test and oral glucose tolerance test. No changes to procedures. See dynamic function tests. |
revision 2020.001
|